logo

CLOV

Clover Health·NASDAQ
--
--(--)
--
--(--)
4.84 / 10
Netural

Fund flow is good (7.68/10) with ~48% inflow across all size brackets, though trends are negative. Analyst sentiment is split: one Strong Buy, one Neutral, with low historical win rates, yielding a neutral overall outlook.

FundamentalSentiment(4.84)Technical
Fund Flow Rating
Analyst RatingStrong Buy

Wall Street Opinions

Strong Buy

Strong Buy

50%

Buy

0%

Hold

0%

Sell

0%

Strong Sell

0%

Date2026-03-20
InstitutionCanaccord Genuity
Times predicted4
Historical Win Rate25.0%
Is money flowing into or out of CLOV?
  • CLOV holds a Bearish analyst rating, with 50% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 4.84/10 (Netural).